Unprecedented effect of vitamin D3 on T-cell receptor beta subunit and alpha7 nicotinic acetylcholine receptor expression in a 3-nitropropionic acid induced mouse model of Huntington's disease

被引:3
|
作者
Manjari, S. K., V [1 ]
Abraham, Sharon Mariam [1 ]
Poornima, R. [1 ]
Chaturvedi, Rajneesh Kumar [2 ]
Maity, Shuvadeep [1 ]
Komal, Pragya [1 ]
机构
[1] Birla Inst Technol & Sci BITS Pilani, Dept Biol Sci, Hyderabad Campus, Hyderabad 500078, Telangana, India
[2] CSIR Indian Inst Toxicol Res, Dept Toxicol & Hlth assessment, Vishvigyan Bhavan,31,Mahatma Gandhi Marg,POB 80, Lucknow 226001, Uttar Pradesh, India
来源
IBRO NEUROSCIENCE REPORTS | 2023年 / 15卷
关键词
T-cell receptor-beta subunit (TCR-& beta; Huntington's disease (HD); Immune receptors; & alpha; 7 nicotinic acetylcholine receptors(& alpha; 7; nAChRs; Vitamin D3 (VD); Nuclear factor kappa B(NF-& kappa; B); Interleukin-6 (IL-6); NEURODEGENERATIVE DISEASES; CORTICAL INTERNEURONS; MITOCHONDRIAL TOXIN; ALZHEIMERS-DISEASE; ACTIVATION; SYSTEM; DYSFUNCTION; CONTRIBUTES; MECHANISMS; NEURONS;
D O I
10.1016/j.ibneur.2023.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: 3-NP induction in rodent models has been shown to induce selective neurodegeneration in the striatum followed by the cortex (Brouillet, 2014). However, it remains unclear whether, under such a neurotoxic condition, characterized by neuroinflammation and oxidative stress, the gene expression of the immune resident protein, T-cell receptor beta subunit (TCR-ss), alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChRs), the nuclear factor kappa B (NF-kappa B), inflammatory cytokines (TNF-alpha and IL-6), and antioxidants (Cat and GpX4) get modulated on Vitamin D3 (VD) supplementation in the central nervous system. Methods: In the present study, real-time polymerase chain reaction (RT-PCR) was performed to study the expression of respective genes. Male C57BL/6 mice (8-12 weeks) were divided into four groups namely, Group I: Control (saline); Group II: 3-NP induction via i.p (HD); Group III: Vitamin D3 (VD) and Group IV: (HD + VD) (Manjari et al., 2022). Results: On administration of 500IU/kg/day of VD, HD mice showed a significant reduction in the gene expression of the immune receptor, TCR-ss subunit, nuclear factor kappa B (NF-kappa B), inflammatory cytokines, and key antioxidants, followed by a decrease in the acetylcholinesterase activity. Conclusion: A novel neuroprotective effect of VD in HD is demonstrated by combating the immune receptor, TCR ss gene expression, antioxidant markers, and inflammatory cytokines. In addition, HD mice on VD administration for 0-15 days showed an enhancement in cholinergic signaling with restoration in alpha 7 nAChRs mRNA and protein expression in the striatum and cortex.
引用
收藏
页码:116 / 125
页数:10
相关论文
共 11 条
  • [1] Beta-Boswellic Acid Reverses 3-Nitropropionic Acid-Induced Molecular, Mitochondrial, and Histopathological Defects in Experimental Rat Model of Huntington's Disease
    Albekairi, Thamer H.
    Kamra, Arzoo
    Bhardwaj, Sudeep
    Mehan, Sidharth
    Giri, Aditi
    Suri, Manisha
    Alshammari, Abdulrahman
    Alharbi, Metab
    Alasmari, Abdullah F.
    Narula, Acharan S.
    Kalfin, Reni
    BIOMEDICINES, 2022, 10 (11)
  • [2] Beneficial Effect of Xanthohumol, a Prenylated Flavanoid, on 3-Nitropropionic Acid Induced Huntington's Disease in a Rat Model
    Zhang, Junwu
    Li, Peiyu
    Wang, Xiuping
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (09): : 1867 - 1874
  • [3] Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease
    Domenici, Maria Rosaria
    Chiodi, Valentina
    Averna, Mirko
    Armida, Monica
    Pezzola, Antonella
    Pepponi, Rita
    Ferrante, Antonella
    Bader, Michael
    Fuxe, Kjell
    Popoli, Patrizia
    PURINERGIC SIGNALLING, 2018, 14 (03) : 235 - 243
  • [4] Alpha7 Nicotinic Acetylcholine Receptor Down Regulation Impairs Mitochondrial Function in Streptozotocin-induced Sporadic Alzheimer's Disease Model in Rats
    Singh, Niraj Kumar
    Garabadu, Debapriya
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021, 55 (01) : 153 - 163
  • [5] Possible Neuroprotective Effect of Withania somnifera Root Extract Against 3-Nitropropionic Acid-Induced Behavioral, Biochemical, and Mitochondrial Dysfunction in an Animal Model of Huntington's Disease
    Kumar, Puneet
    Kumar, Anil
    JOURNAL OF MEDICINAL FOOD, 2009, 12 (03) : 591 - 600
  • [6] Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease
    Kumar, Puneet
    Kalonia, Harikesh
    Kumar, Anil
    BEHAVIOURAL PHARMACOLOGY, 2010, 21 (03): : 217 - 230
  • [7] Adenosine A1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington's disease via stimulation of TrKB/PI3K/Akt/CREB/BDNF pathway in 3-nitropropionic acid rat model
    Rabie, Mostafa A.
    Ibrahim, Heba I.
    Nassar, Noha N.
    Atef, Reham M.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 369
  • [8] Decrease of KATP channel expression through D3 receptor-mediated GSK3(3 signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model
    Kuo, Yi-Ying
    Pen, Sih-Yu
    Cheng, Chia-Hui
    Ho, Wan-Chen
    Chen, Ching-Yi
    Wu, Wen-Chung
    Chou, Ho-Hsuan
    Chen, Jung-Yao
    Lin, Ching-Han
    Lin, Jen-Feng
    Yang, Shi-Bing
    Chen, Pei-Chun
    LIFE SCIENCES, 2024, 359
  • [9] The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington's disease in rats: shifting paradigms in Huntington's disease treatment
    Wanas, Hanaa
    Rabie, Mostafa Adel
    Aboulhoda, Basma Emad
    Ramadan, Nagwa Mahmoud
    Abdelwahab, Sahar
    Abdallah, Sara Sayed Kadry
    Ali, Eid Nassar
    Khayruddeen, Leyan Nasruddeen
    Elhassan, Yasir Hassan
    Alghabban, Hadel Mahroos
    Abdelsalam, Shaimaa Mohamed
    Khalifa, Amira Karam
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)
  • [10] Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model
    Elgueta, Daniela
    Contreras, Francisco
    Prado, Carolina
    Montoya, Andro
    Ugalde, Valentina
    Choval, Ornella
    Villagra, Roque
    Henriquez, Claudio
    Abellanas, Miguel A.
    Aymerich, Maria S.
    Franco, Flame
    Pacheco, Rodrigo
    FRONTIERS IN IMMUNOLOGY, 2019, 10